期刊文献+

溃疡性结肠炎患者使用美沙拉嗪缓释剂诱发急性胰腺炎 被引量:2

原文传递
导出
摘要 患者男.21岁.因间断黏液血便3月余于2011年5月31日入院,血便约3次/d。体检有左腹压痛,无其他阳性症状及体征。入院后实验室检查:WBC 12.4×10^9/L,红细胞沉降率14mm/1h,C反腹蛋白23.8mg/L.粪便常规隐血试验阳性。肠镜检查提示:
出处 《中华消化杂志》 CAS CSCD 北大核心 2012年第5期347-348,共2页 Chinese Journal of Digestion
  • 相关文献

参考文献11

  • 1WU Guo-liang,TANG Ye-qiu,SU Xiang-xi,胡伏莲,林庚金,袁爱力,谢鹏雁,刘建湘,袁耀宗,许国铭,张小晋,杨昭徐,赵英恒,杨见权,周兰,ZHOU Lan.美沙拉嗪治疗炎症性肠病的疗效及安全性:—全国多中心临床研究[J].中国新药杂志,2001,10(3):201-204. 被引量:22
  • 2l.oftus EV Jr, Kane SV, Bjorkman D. Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis. Aliment Pharmacol Ther, 2004,19 : 179-189. 被引量:1
  • 3Gisbert JP, Gonzdlez Lama Y, Mat6 J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review, lnflamm Bowel Dis, 2007,13 : 629-638. 被引量:1
  • 4Lamsiah T, Moudden K, Baaj M, et al. Interstitial pneumonia related to mesalamine. Gastroenterol Clin Biol, 2010,34:224-226. 被引量:1
  • 5Sossai P. Cappellato MG, Stefani S. Can a drug-induced pulmonary hypersensitivity reaction be dose-depe:cent? Acase with mesalamine. Mt Sinai J Med, 2001,68:389-395. 被引量:1
  • 6Wiesen A, Wiesen J, l.imaye S, et al. Mesalazine-indueed aplastic anemia. Am J Gastroenterol, 2009,104:1063. 被引量:1
  • 7Sposato B, Allegri MP, Riecardi MP, el ai. Mesalazine- induced multi organ hypersensitivity Clin Drug Investig, 2010,30:413-417. 被引量:1
  • 8Bermejo F, l.opez-Sanromaa A, Taxonera C, et al. Acute pancreatitis in inflammatory bowel disease, with speciaI reference to azathioprine-indueed pancreatitis. Aliment Pharmacol Ther, 2008,28 : 623-628. 被引量:1
  • 9Nitsche CJ, Jamieson N, Lerch MM, et al. Drug induced panereatitis. Best Pract Res Clin Gastroenterol, 2010, 24: 143-155. 被引量:1
  • 10Adachi E, Okazaki K, Matsushima Y, et al. Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis. Int J Pancreatol, 1999, 25: 217-221. 被引量:1

二级参考文献7

  • 1ChristensenLA.5Aminosalicylicacidcontainingdrugs.Delivery ,fate ,andpossibleclinicalimplicationsinman[].DanMedBull.2000 被引量:1
  • 2MunakataA,YoshidaY,MutoT ,etal.Double blindcomparativestudyofsulfasalazineandcontrolled releasemesalazinetabletsinthetreatmentofactiveulcerativecolitis[].Journal of Gastroenterology.1995 被引量:1
  • 3PrakashA,MarkhamA.Oraldelayed releasemesalazine :areviewofitsuseinulcerativecolitisandCrohn’sdisease[].Drugs.1999 被引量:1
  • 4AllgayerH.Sulfasalazineand 5 ASAcompounds[].Gastroen terolClinNorthAm.1992 被引量:1
  • 5GiafferMH,O’brienCJ,HoldsworthCD.Clinicaltolerancetothree 5 aminosalicylicacidreleasingpreparationsinpatientswithinflammatoryboweldiseaseintolerantorallergictosulphasalazine[].Alimentary Pharmacology and Therapeutics.1992 被引量:1
  • 6NakajimaH,MunakataA,YoshidaY.Adverseeffectsofsul fasalazineandtreatmentofulcerativecolitiswithmesalazine[].JGastroenterol (Suppl )∶. 被引量:1
  • 7HussainFN,AjjanRA,RileySA.Doseloadingwithdelayed re leasemesalazine :astudyoftissuedrugconcentrationsandstan dardpharmacokineticparameters[].BrJClinPharmacol.2000 被引量:1

共引文献21

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部